Cargando…

Managing glycaemia in older people with type 2 diabetes: A retrospective, primary care‐based cohort study, with economic assessment of patient outcomes

AIMS: To describe the relative health and economic outcomes associated with different second‐line therapeutic approaches to manage glycaemia in older type 2 diabetes patients requiring escalation from metformin monotherapy. MATERIALS AND METHODS: The Clinical Practice Research Datalink database was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gordon, Jason, McEwan, Phil, Evans, Marc, Puelles, Jorge, Sinclair, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412932/ https://www.ncbi.nlm.nih.gov/pubmed/28026911 http://dx.doi.org/10.1111/dom.12867

Ejemplares similares

Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study
por: Gordon, Jason, et al.
Publicado: (2018)

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus
por: Gordon, Jason, et al.
Publicado: (2016)

Factors Predictive of Weight Gain and Implications for Modeling in Type 2 Diabetes Patients Initiating Metformin and Sulfonylurea Combination Therapy
por: Gordon, Jason P., et al.
Publicado: (2015)

Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn’s disease: a systematic review and clinician surveys
por: Gordon, Jason P., et al.
Publicado: (2015)

Glycaemia and hand grip strength in aging people: Guangzhou biobank cohort study
por: Liang, Xue, et al.
Publicado: (2020)

Evaluation of Insulin Use and Value for Money in Type 2 Diabetes in the United Kingdom
por: Gordon, Jason, et al.
Publicado: (2013)

A Retrospective, Case-Note Survey of Type 2 Diabetes Patients Prescribed Incretin-Based Therapies in Clinical Practice
por: Evans, Marc, et al.
Publicado: (2012)

Retrospective Database Analysis Evaluating the Clinical Outcomes of Changing Treatment of People with Type 2 Diabetes Mellitus (T2DM) from Other DPP-4 Inhibitor Therapy to Alogliptin in a Primary Care Setting
por: Strain, W. David, et al.
Publicado: (2019)

Glycaemia and critical care outcomes
por: Cecconi, M, et al.
Publicado: (2014)

Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan
por: Matsumoto, Tetsuya, et al.
Publicado: (2021)

Body mass index and risk of obesity‐related conditions in a cohort of 2.9 million people: Evidence from a UK primary care database
por: Haase, Christiane L., et al.
Publicado: (2020)

What Next After Metformin? Thinking Beyond Glycaemia: Are SGLT2 Inhibitors the Answer?
por: Evans, Marc, et al.
Publicado: (2019)

Untangling glycaemia and mortality in critical care
por: Uyttendaele, Vincent, et al.
Publicado: (2017)

Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK
por: Bennett, Hayley, et al.
Publicado: (2014)

Healthcare resource implications of hypoglycemia-related hospital admissions and inpatient hypoglycemia: retrospective record-linked cohort studies in England
por: McEwan, Philip, et al.
Publicado: (2015)

Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review
por: Chiang, Jason I., et al.
Publicado: (2018)

Impact of postprandial glycaemia on health and prevention of disease
por: Blaak, E E, et al.
Publicado: (2012)

The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus
por: McEwan, Phil, et al.
Publicado: (2016)

A Systematic Review to Assess the Impact of Hyperbaric Oxygen Therapy on Glycaemia in People with Diabetes Mellitus
por: Baitule, Sudhanshu, et al.
Publicado: (2021)

Real‐World Associations of Renin–Angiotensin–Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New‐Onset Chronic Kidney Disease or Heart Failure in the United Kingdom
por: Linde, Cecilia, et al.
Publicado: (2019)

Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database
por: Haase, Christiane Lundegaard, et al.
Publicado: (2021)

The Relation of Glycosuria to Glycæmia and the Determination of the Renal Threshold for Glucose
Publicado: (1932)

High Adiposity Is Associated With Higher Nocturnal and Diurnal Glycaemia, but Not With Glycemic Variability in Older Individuals Without Diabetes
por: Noordam, Raymond, et al.
Publicado: (2018)

Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study
por: James, Glen, et al.
Publicado: (2021)

Estimating the Clinical and Economic Benefit Associated with Incremental Improvements in Sustained Virologic Response in Chronic Hepatitis C
por: McEwan, Phil, et al.
Publicado: (2015)

Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design
por: Sugrue, Daniel M., et al.
Publicado: (2019)

Burden of Illness in UK Subjects with Reported Respiratory Infections Vaccinated or Unvaccinated against Influenza: A Retrospective Observational Study
por: Pockett, Rhys D., et al.
Publicado: (2015)

Remifentanil for postoperative analgo-sedation: effects on glycaemia and HOMA score
por: Chelazzi, C, et al.
Publicado: (2010)

Glycaemia influences glucose metabolism in sepsis during hyperinsulinemic clamp
por: Rušavý, Z, et al.
Publicado: (1998)

Role of POMC and AgRP neuronal activities on glycaemia in mice
por: Üner, Aykut Göktürk, et al.
Publicado: (2019)

Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
por: Evans, Marc, et al.
Publicado: (2019)

Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme
por: Gordon, Jason, et al.
Publicado: (2020)

Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary care-based analysis
por: Sharplin, Peter, et al.
Publicado: (2009)

Seremban Cohort Study (SECOST): a prospective study of determinants and pregnancy outcomes of maternal glycaemia in Malaysia
por: Yong, Heng Yaw, et al.
Publicado: (2018)

Drinking Carling Out of Stella Glasses: People and Place in the Missing Middle
por: McEwan, Kathryn
Publicado: (2021)

Management of Type 2 Diabetes in Older People
por: Abdelhafiz, Ahmed H., et al.
Publicado: (2013)

Associations between multimorbidity and glycaemia (HbA1c) in people with type 2 diabetes: cross-sectional study in Australian general practice
por: Chiang, Jason I, et al.
Publicado: (2020)

Evaluation of Fast Glycaemia in Hypertonic Population that Suffer from Diabetes: The Importance of Self-Monitoring of Glycemic Level and the Effects of Interactions, with the Aim of Reducing the Levels of Fast Glycaemia in These Patients
por: Lashi, Edlira, et al.
Publicado: (2018)

The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program
por: Shiri, Tinevimbo, et al.
Publicado: (2022)

Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections
por: Bennett, Hayley, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pi3ffuah0d1k8fpl0fo9p09veu